Posted on 10/05/2021 1:01:09 PM PDT by NoLibZone
Denny Kim, M.D. appointed Senior Vice President, Chief Safety Officer Published: Oct. 4, 2021 at 4:05 PM EDT|Updated: 23 hours ago GAITHERSBURG, Md., Oct. 4, 2021 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced the appointment of Denny Kim, M.D., MPH to the newly created role of Senior Vice President, Chief Safety Officer and Head of Global Vaccine Safety. Dr. Kim will report to Filip Dubovsky, M.D., MPH, FAAP, Executive Vice President and Chief Medical Officer. Novavax also announced the promotions of Raburn Mallory, M.D. to Senior Vice President, Head of Clinical Development, and Marco Cacciuttolo, Ph.D. to Senior Vice President, Process and Analytical Development.
Dr. Kim brings nearly two decades of infectious disease, clinical trial and safety experience to Novavax. He joins the company from Johnson & Johnson (J&J), where he was part of the Office of the Chief Medical Officer with oversight for safety strategies and activities across all therapeutic areas, including direct management responsibilities for the safety of the J&J/Janssen COVID-19 vaccine. Previously, he built and led the global Patient Safety and Pharmacovigilance function at Horizon Pharma, developed a new safety function within Takeda's Vaccine Business Unit, and served as Therapeutic Area Safety Head at both Takeda and Astellas. He holds a Doctor of Medicine from University of Chicago Pritzker School of Medicine, a Master of Public Health from Johns Hopkins University Bloomberg School of Public Health and a Bachelor of Arts from Yale University.
"We welcome Denny at an exciting time for Novavax as we finalize our regulatory filings and transition into a commercial-stage organization," said Dr. Dubovsky. "His leadership and COVID-19 vaccine experience uniquely equip him to lead a best-in-class safety and pharmacovigilance function at Novavax."
Dr. Raburn Mallory has been promoted to Senior Vice President and Head of Clinical Development. In his new role, Dr. Mallory will lead the clinical development organization, provide strategic direction for the life-cycle management of Novavax' vaccines and play a key role in regulatory filings. Prior to joining Novavax, Dr. Mallory was Vice President of Clinical Development and the Global Clinical Lead for the COVID-19 and influenza vaccines at AstraZeneca. Prior to that, he was Medical Director for DynPort Vaccine Company. Earlier in his career, Dr. Mallory was a Robert Wood Johnson Clinical Scholar at Johns Hopkins University and an Academic Hospitalist at Yale-New Haven Hospital, where he completed residency training. He holds a Doctor of Medicine from Yale University School Medicine and a Bachelor of Arts from Brown University.
Dr. Marco Cacciuttolo has been promoted to Senior Vice President of Process and Analytical Development. In his new role, he will continue to ensure the technical quality and safety of Novavax' vaccine candidates. Dr. Cacciuttolo has more than three decades of biochemical engineering experience and has successfully developed commercial processes for many products. Prior to joining Novavax in July 2020, he served as head of manufacturing at Nosocomial Vaccine Corporation, as chief operating officer at PathoVax LLC and as managing director of Batavia Biosciences. He holds a doctorate in Biochemical Engineering from the University of Maryland, Baltimore and a Bachelor of Science from Pontifical Catholic University of Valparaíso.
"We also congratulate Raburn and Marco on their promotions, which reflect their meaningful contributions to advancing NVX-CoV2373, our recombinant nanoparticle protein-based COVID-19 vaccine candidate," continued Dr. Dubovsky. "We look forward to their collective contributions as we move toward commercialization."
About Novavax Novavax, Inc. (Nasdaq: NVAX) is a biotechnology company that promotes improved health globally through the discovery, development and commercialization of innovative vaccines to prevent serious infectious diseases. The company's proprietary recombinant technology platform combines the power and speed of genetic engineering to efficiently produce highly immunogenic nanoparticles designed to address urgent global health needs. Novavax is conducting late-stage clinical trials for NVX-CoV2373, its vaccine candidate against SARS-CoV-2, the virus that causes COVID-19. NanoFlu™, its quadrivalent influenza nanoparticle vaccine, met all primary objectives in its pivotal Phase 3 clinical trial in older adults. Both vaccine candidates incorporate Novavax' proprietary saponin-based Matrix-M™ adjuvant to enhance the immune response and stimulate high levels of neutralizing antibodies.
Diversity and Inclusion complaints arriving in three, two...
Nova lox!!!
GOOD STUFF!!!
Bagel, cream cheese, onion, tomato...
Some good living!
Novavax is the Solyndra of the pharmaceutical industry
Why? Because Kim is a Korean surname?
They’re all men.
Hopefully this frankenshot is merely ineffective instead of outright killing the patient like others do.
Unfortunately it has the same ethical profile as the currently available shots. I don’t begrudge anyone receiving the shots buts it’s pretty discouraging that there’s no ethically developed alternative for people who consciously object to the usual pharmaceutical development/testing paradigm.
damn onion correct
Hopefully this frankenshot is merely ineffective instead of outright killing the patient like others do.
~~~~~~~~~~~~~~~~~
Novavax is pure spike proteins - very damaging. No mRNA or DNA. Just spike proteins which have already been shown to be damaging, but of course, never acknowledged by the Medical Politburo
Posted on 6/16/2021, 2:03:15 AM by ransomnote
Dr. Campbell notes that he's reading from a press release and the vaccine research has not been peer reviewed yet.
ransomnote: I was wondering why there were so many news articles for Novavax all dated 6/14. Almost like press releases = free advertising from MSM. I saw elsewhere that Novavax development was also supported by the Bill & Melinda Gates foundation, among others.
How Novavax works:
DNA designed to make the spike proteins is put into another virus and that virus is put into moth cells. The DNA instructs the moth cells to mass produce the spike proteins, then the spike proteins are harvested (purified) from the moth cells.
The spike cells stick together and have the antigenic properties of the Sars 2 Covid virus, without the actual presence of the Covid virus.
ransomnote: Covid spike proteins are causing harm in other vaccines. Inventor Of mRNA Vaccine Technology: Spike Protein Is Dangerous, Its Cytotoxic. The FDA Was Warned About It Months Ago
First case of postmortem study in a patient vaccinated against SARS-CoV-2 [Spike Protein in every organ in his body!] or transcript:
Dr. Mercola Explains Dr. Bridle’s Bombshell Revelations Regarding Spike Proteins from Vaccines
Compared with the mRNA vaccines and DNA 'vaccines', which tell your own body cells to produce the spike protein, the Novavax is designed to directly inject the spike proteins into your body.
2:1 trials mean twice the number of vaccinated participants compared to unvaccinated participants.
Novavax's efficacy claim is 100% protection against moderate and severe disease. Claim- all deaths and hospitalizations occurred in control group. Claim - its 90% effective overall and 91% effective in high risk groups. This data applies to their Jan 25 to April 30 trial duration.
ransomnote: Efficacy after that 3 month window unknown. For those new to manufacturer's efficacy claims, you may want to read this thread: Check Your Understanding Of The "Efficacy" Claims For 'Vaccines': The Claim "95% Effective" Means A Fraction Of 1% Of The Vaccinated Are "Protected" For 2 Months
Novavax was tested against a Covid variant very similar to, but not the same as, the original Covid virus.
Are you referring to aborted fetal cell lines?
It’s unfortunate how many medicines are developed with fetal cell lines. I can’t even use Tylenol or aspirin.
Yes, another vaccine tested on cells from dissected-alive babies. America seems to want a Chastisement.
So, no uncontrolled release of spike proteins and the adjuvant used further allows a tiny amount to activate enough immune cells.
The author in the following mentions the concern with the spike proteins, but states the amount used, if a problem, would have shown up in the testing.
https://seekingalpha.com/article/4435062-novavax-vaccine-data-and-spike-proteins-in-general
Every doctor i spoke with who is pro-ivermectin, unabashedly admitted from the beginning the virus was created in a chinese lab, and believes this is all politically motivated, has told me the Novavaxx vaccine is the best, the safest and they wish they could have taken it.
They also told me it won’t be approved in America for another year as merck and pfizer have millions more dosages they need to sell.
Oh well.
I still like the saltness of just plain lox, and they cost less too.
| ConservativeMind wrote: |
| The amount of spike protein is minuscule, compared with the viral and mRNA vaccines and what they release. So, no uncontrolled release of spike proteins and the adjuvant used further allows a tiny amount to activate enough immune cells. The author in the following mentions the concern with the spike proteins, but states the amount used, if a problem, would have shown up in the testing. https://seekingalpha.com/article/4435062-novavax-vaccine-data-and-spike-proteins-in-general |
I have to hope that consumers have discovered by now that nothing the pharmas said about their products were true. Nothing. And, fake PCR tests are used to determine efficacy, and efficacy has not proven true.
So Novavax shows up and we're supposed to forget we can't trust them or the CDC or anyone pushing a 'vaccine' for an illness that is generally over 99.9% survivable and for which most of us by now have more robust, reliable antibodies.
I read the story spun about how Novavax theoretically works - since there's no valid Covid test, no isolated samples of the Covid virus for them to use - they have no valid information about efficacy or the 'wild type' protein' to which they compare their product. These are lies. We can admit that they are lying to us and want to harm us. The CDC and other pharmas are pushing toxins, twisting arms, stripping employment etc. for a reason adn they aren't just going to 'let' a harmless, uneccessary 'vaccine' on the market. Novavax has to be damaging or they won't allow us to have it.
Bottom line: WHEN IS THEIR COVID VACCINE GOING TO BE AVAILABLE??
RE: Novavax is the Solyndra of the pharmaceutical industry
Why? How much money did American taxpayers sink into this company?
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.